echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > In addition to "caution in elderly patients", famotidine also has these precautions!

    In addition to "caution in elderly patients", famotidine also has these precautions!

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only



    What are the common drugs for the digestive system? Search for "evidence-based medicine" to find out!


     

    Famotidine is a histamine 2 (H2) receptor antagonist widely used in digestive tract diseases
    such as peptic ulcer, heartburn, and acute gastric mucosal lesions.

    In terms of medication safety, in addition to the cautious use of the elderly, you should also pay attention to these precautions!







    Liver and kidney insufficiency should be used with caution (1) This product should not be used continuously for more than 7 days, and the symptoms are not relieved, and a doctor or pharmacist should be
    consulted

    (2) Please consult a doctor or pharmacist
    for children's dosage.

    (3) Patients with hepatic insufficiency and children should be used
    with caution.

    (4) This product is mainly excreted by the kidneys, and patients with renal insufficiency should be used
    with caution.

    (5) If you overdose or have serious adverse reactions, you should seek medical attention
    immediately.

    (6) Those who are allergic to this product are banned, and those who are allergic should use
    with caution.

    (7) It is forbidden to use
    this product when the properties change.

    (8) Keep this product out of
    reach of children.

    (9) This product will have hidden gastric cancer symptoms, so it should be administered
    after excluding tumors and esophageal and gastric varices.

    (10) In the process of treatment, full observation should be carried out, and the minimum use of treatment limited to treatment according to the condition (invasive stress response is about 3 days, others are about 7 days), in addition, attention should be paid to observing blood images, liver function, etc.
    [1-11].









    Central nervous system adverse reactions
    Older patients treated with famotidine tablets and patients with moderate to severe renal impairment have experienced central nervous system (CNS) adverse effects
    including confusion, delirium, hallucinations, disorientation, agitation, seizures, and lethargy.
    Since the plasma concentration of famotidine in patients with impaired renal function is higher than in patients with normal renal function, it is recommended to adjust the dose
    in patients with renal impairment.








    Complicated by gastric malignancy
    In adults, famotidine can conceal the symptomatic response
    of gastric malignancies.
    If famotidine is not effective or recurs with early symptoms, a diagnosis of gastric malignancy is indicated [12][14].


    What other drugs are available for peptic ulcers? How to deal with drug overdose?

    More commonly used drugs for the digestive system, on "clinical decision-based medicine" you want to see, here are all! 👇


    References [1] American Geriatrics Society Beers Criteria Update Expert Panel:American Geriatrics Society 2019 updated AGS Beers Criteria(R)for potentially inappropriate medication use in older adults.
    J Am Geriatr Soc 2019; 67(4):674-694.
    [2] Drug information: Famotidine tablets, Harbin Pharmaceutical Group Sanjing Qianhe Pharmaceutical Co.
    , Ltd.
    , Sinopharm Quasi-word H20093044
    [3] Drug information: famotidine tablets, Jiangsu Hengrui Pharmaceutical Co.
    , Ltd.
    , Sinopharm H32023658
    [4] Drug information: Famotidine chewable tablets, Guangzhou Bossero Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20041793
    [5] Drug information: famotidine capsules, Sinopharm Shantou Jinshi Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20023398; 2015/11/30.
    [6]Drug information: famotidine dispersible tablets, Sichuan Qili Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20030538; 2013/12/19.
    [7]Drug information: famotidine granules, Zhejiang Yadong Pharmaceutical Co.
    , Ltd.
    , Sinopharm H10950256; 2007/04/18.
    [8]Drug information: famotidine injection, Zhejiang Zhenyuan Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20046639; 2015/12/01.
    [9] Drug information: famotidine granules, Sinopharm Rongsheng Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20033269
    [10] Drug information: Famotidine for injection, Shanxi Kangbao Biological Products Co.
    , Ltd.
    , Sinopharm H10970269; 2013/12/05.
    [11] Drug information: Famotidine for injection, Yamauchi Pharmaceutical Co.
    , Ltd.
    , Yamanouchi Pharmaceutical Co.
    , Ltd.
    , Sinopharm J20030014
    [12]Product Information:FAMOTIDINE tablet,Alembic Pharmaceuticals Inc.
    ,Updated October 4,2021.
    [13]Product Information:FAMOTIDINE-famotidine injection,solution,Fresenius Kabi USA,LLC,Updated May 10,2021.
    [14]Product Information:FAMOTIDINE powder,for suspension,Zydus Pharmaceuticals USA Inc.
    ,Updated April 22,2021.
    [15]Product Information:FAMOTIDINE powder,for suspension,Hi-Tech Pharmacal Co.
    ,Inc.
    ,Updated October 2,2020.
    ▼▼Click to read the original article to download the App


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.